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Exposure to environmental tobacco smoke (ETS) among individuals who have never smoked
tobacco products has been well established as a risk factor for lung cancer. Most of the
epidemiologic evidence for this association has come from studies of exposure to a spouse who
smokes. Fewer studies have explicitly evaluated this risk relationship for workplace sources of ETS
exposure. These are reviewed here in the context of study design issues and their contributions to
the overall evidence for risks of ETS exposure in the workplace. Although most studies have low
power to detect workplace risk estimates in the modest range suggested by the larger studies, risk
estimates tend to be consistent with those for exposure from a smoking spouse. Key words:
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Environmental tobacco smoke (ETS) exposure
has been well established as a risk factor for
lung cancer in individuals who have never
smoked tobacco products (1-5). Most ofthe
human health evidence contributing to this
conclusion has come from studies of non-
smoking women married to husbands who
smoked. The focus on spouses' smoking
habits, particularly in studies where women
may be more likely to work outside the home,
may underestimate the true risk relationship
by failing to account for other major daily
opportunities for exposure. This is empha-
sized by a number of exposure assessment
studies suggesting that workplace sources of
ETS exposure may be as great as the levels
measured in households and may also be an
especially important source ofexposure for
some occupational groups (69). These obser-
vations, together with concerns for the possi-
bility ofpotentiating effects ofETS with other
workplace toxicants, argue for a direct estima-
tion ofworkplace-specific risks. Although
there are now dozens ofepidemiologic studies
evaluating risks for lung cancer in nonsmokers
living with spouses who smoke, relatively few
have also examined workplace sources ofETS.
Two very comprehensive reviews ofthe litera-
ture on ETS and lung cancer, by the U.S. and
California Environmental Protection
Agencies, include excellent discussions ofthe
evidence for both spouse/household and
workplace effects (4,5). Both these reviews
suggest a consistency ofrisk estimates for ETS
exposure in these various settings. A recent
detailed assessment by Wells (10) suggests
that the best summary estimate ofrelative risk
for lung cancer specific to sources of ETS
exposure in the workplace from combined
studies is 1.39 (95% confidence interval [95%
CI, 1.15-1.68]). In the present article, we give
an overview ofcurrent epidemiologic evidence
from individual studies that have provided
specific risk estimates for lung cancer
associated with workplace ETS exposures and
extend previous reviews by including data
from four newstudies.
Factorsto Consider in
Assessing Risk Estimates
of ETS Exposure
When evaluating specific estimates oflung
cancer risk, it is important to consider various
issues in the design ofstudies involving ETS
exposure in the workplace. These issues pri-
marily reflect the general challenges in design-
ing and implementing observational studies,
but some have particular relevance for work-
place-associated risks. They include a number
offactors found in the summary tables in this
paper and incorporated in the discussion of
their contributions to the question ofinterest.
Case and control selection criteria are
among the most important features of these
studies. Almost all the studies with data on
workplace exposures have used a case-control
study design. Most have selected cases from
hospital populations, and only a few have
attempted population-based case ascertain-
ment. Because lung cancer in nonsmokers is
such a rare event, it is far easier to identify
and recruit eligible cases in a hospital setting
than in the general population. A particularly
important feature ofstudies oflung cancer is
that the cases are correctly classified as having
lung cancer. There is considerable variation in
the level ofdiagnostic confirmation in pub-
lished studies. Among nonsmokers in particu-
lar, there is a potential for cancer from other
sites that are metastatic to the lung to be mis-
diagnosed as primary lung cancer. Histologic
confirmation levels tend to be higher in hos-
pital-based than in population-based studies.
Conversely, hospital studies generally reflect a
nonrandom series of patients who agree to
interview and seldom contain information on
the pool of eligibles from which they were
drawn. For the population-based studies,
response rates indicate the representativeness
of the study sample. Hospital-based studies
are subject to potential problems ofselection
bias but present a much more efficient
strategy for case recruitment.
One ofthe most critical design features of
a case-control study is the selection criteria
for controls. Hospital-based studies most
often recruit controls from other patient
groups, including patients with other cancers.
To the degree that these reflect smoking-
related conditions, controls in these studies
may be too similar to the cases with respect to
the risk factors of interest. Matching criteria
for controls call for a balance between ade-
quate matching to optimize statistical effi-
ciency and avoidance ofovermatching, which
can result in diminution of power and bias
results to the null.
The correct classification of exposure is
also an important feature but is not always
easy to achieve. Problems in exposure assess-
ment include the choice ofstudy respondents
according to smoking history, method ofelic-
iting information, and source of exposure
information. Some studies have defined non-
smokers as current nonsmokers; hence they
include an unknown proportion of former
smokers. More rigorous designs have defined
nonsmokers as lifetime nonsmokers.
Although the primary method of assessing
workplace ETS exposure in the epidemiologic
literature has relied on questionnaire rather
than on measurement indices, there is consid-
erable variability in how the questions have
been posed. For many existing studies, infor-
mation has been elicited by a single question
on workplace exposure. The use of respon-
dent report also poses a particularly difficult
problem when studying a highly fatal disease
such as lung cancer. Once identified, many
patients do not survive long enough to be
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personally interviewed. As a consequence,
most population-based studies rely on infor-
mation from next of kin. This is a problem
especially troublesome for workplace studies.
Information on environmental tobacco expo-
sure from the spouse may still be quite valid,
especially since the spouse is often the infor-
mant, but proxy respondents (generally fam-
ily members) are much less likely to know
about workplace exposures.
It is important to consider that most of
the studies with information on risk of expo-
sure to ETS in the workplace were neither
explicitly designed to evaluate that association
nor to evaluate workplace factors in general.
As a consequence they have offered limited
information on other risk factors that might
mediate the observed associations with ETS.
This may be particularly important, as some
studies have suggested that passive smokers
may differ on a number ofpotentially relevant
characteristics compared to nonsmokers with-
out reported passive smoke exposure (11-15).
Although diet and family history have been
considered in some studies, especially in more
recent ones, few have addressed other occupa-
tional exposures that might be relevant.
Similarily, most include modest numbers of
subjects and have very low power to detect a
true risk association in a range ofpublic health
interests. In the tables that follow, power has
been computed for the ability of a study to
detect a minimum workplace odds ratio (OR)
of 1.4 [from the summary analysis by Wells
(10)] with an alpha error of0.05. For U.S.
studies (16,17) that did not provide informa-
tion on the prevalence of ETS exposure in
controls, prevalence from the U.S. multicenter
study was used (18). Power was estimated
using the formula from Schlesselman (19) for
studies with an unequal case-control ratio and
the formula from Breslow and Day (20) for
cohort studies.
Epidemiologic Studies with
Risk Estimates of ETS
Exposure in the Workplace
Hospital-Based Studies in
NonsmokingWomen
The most studied population for the influence
ofETS on lung cancer has been women classi-
fied as nonsmokers. Hospital-based studies
with risk estimates of ETS exposure in the
workplace in nonsmoking women are summa-
rized in Table 1 (21-32). Dating back to the
mid-1980s, these studies come from a variety
ofcountries throughout the world. The differ-
ent settings offer great variability in the preva-
lence of exposure. Three are from Asian
locations, including Hong Kong (21,23),
Japan (26), and Taiwan (29), where smoking
rates tend to be quite low among women and
high among men. The recent study from
Russia is particularly interesting, not only
because women have traditionally participated
in the industrial work force in great numbers
but also because ofthe common consumption
ofhigh tar tobacco products (31). Only three
of the studies are from the United States
(22,24,28), two ofthese by Kabat and associ-
ates (22,28). Most of the observations for
nonsmoking populations are nested in larger
studies oflung cancer. With the exception of
the studies by Koo et al. (21,23) and Nyberg
et al. (30), all used hospital controls.
The two reports by Kabat and colleagues
(22,28) are part of a larger study oflung
cancer conducted in several metropolitan U.S.
hospitals. The 1984 report reflects preliminary
findings from a group ofenrolled cases from
whom passive smoking information was
elicited late in the course of the study.
Subsequent interview protocols were enhanced
in a later phase of the parent study to include
greater detail on passive smoking. Together
these studies suggested a much higher preva-
lence ofETS exposure at work than at home.
The control series employed in the studies by
Kabat and colleagues included a large propor-
tion of persons with cancer of other sites,
including some cancer types now thought to
have an association with tobacco exposure.
Koo and associates (21,23) conducted a
study of lung cancer patients in Hong Kong
hospitals. The later report appears to be an
Table 1. Hospital-based studies with estimates ofworkplace ETS exposure risks for lung cancer in nonsmoking women.
Figure Study, location Cases/ Work Spouse Power(/)
label (reference) controls Control selection Workplace measure ORa ORa OR = 1.4
Hi Koo et al., 1983 56/85 Community Unknown: use of semi- 1 ob 0.81 25
Hong Kong (21) Match: age,district, SES status structured interview
H2 Kabat and Wydner, 53/53 Hospital Currentjob exposure 0.7c 0.8c 22
1984, U.S. (22) Match: age, race, hospital (60% othercancers)
H3 Koo et al., 1984, 88/137 Community Unknown: use of semi- 1.2d 1 3d 19
Hong Kong (23) Match: age, district, SES status structured interview
H4 Garfinkel et al., 134/402 Hospital > Occasional: last 5 yr 0.9 (0.7-1.2) 1.2 (0.9-1.6) 42
1985, U.S. (24) Match: age, hospital (colon cancer controls) Last 25 yr 0.9(0.7-1.2)e 1.2 (0.9-1.5) 25
H5 Lee et al., 1986, 15/158 Hospital Regular exposure 0.6 0.6 12
England (25) Married only Match: age, hospital, region, ward (time notspecified) (15cases) (32 cases)
H6 Shimizu etal., 90/163 Hospital Smoker in workplace 1.2 1.1 35
1988, Japan (26) Match: age, hospital (56% other cancers) (time not specified)
H7 Kalandidi et al., 89/118 Hospital Number of smokers in closed 1.1(0.2-4.9) 2.1 (1.1-4.1) 22
1990, Athens (27) Match: admission week(fracture, orthopedics) space (time not specified) Top quartile
H8 Kabat et al., 1995, 58/139 Hospital For four jobs lasting> 1 yr 1.2(0.6-2.1) 1.1(0.6-1.9) 26
U.S. (28) Match: age, hospital (61% other cancers)
H9 Ko et al., 1997, 105/105 Hospital Lifetime exposure from 1.1 (0.4-3.0) 1.3(0.7-1.9) 20
Tiawan (29) Match: age (outpatients) coworkers
H10 Nyberg et al., 1998, 89/163 Community Details from the IARC core 1.6 (0.8-3.1) 1.1 (0.6-1.9) 31
Sweden (30) Match: age, hospital catchment area questionnaire
Hi1 Zaridze et al., 1998, 189/358 Hospital Jobs in last 20 yr 0.9(0.6-1.4) 1.5(1.1-2.2) 46
Moscow (31) Match: hospital (oncology patients)
H12 Boffetta etal., 509/1010 Hospital (5 centers) Details from a common 1.2 (0.9-1.5) 1.1(0.9-1.4) 93
1998, IARC (32) Community (6 centers) questionnaire
Both (1 center)
SES, socioeconomic status. 'Odds ratios for studies H1-H6 are crude; the remainder adjust for age and other factors. bCalculated from Table 4 of the referenced paper. cCalcuated from Table 3 of the ref-
erenced paper. dCalculated from Table 2 ofthe referenced paper. e95% Cl has been corrected by Wells (10) to be 0.6-1.6.
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update of the earlier, but no information is
given on the time period for case ascertain-
ment in either. Several features ofthese inves-
tigations make it difficult to assess the impact
ofa number ofpotential sources ofbias. The
number ofparticipating lung cancer patients
was estimated by the authors to represent
slightly less than 25% ofeligible cases, and the
authors indicate that cases were drawn primar-
ily from outpatient services. Little information
is provided on how community controls were
selected. Information was gathered by a semi-
structured interviewing technique, and the cri-
teria used for classifying workplace exposures
are unclear. Both reports suggest null ETS
associations with both household and work-
place exposures, although the power to detect
such an association was quite low. Unlike
those in the U.S. studies by Kabat and
Wynder (22) and Kabat et al. (28), the Hong
Kong controls reported a high prevalence of
household exposure to ETS but very low
prevalence ofworkplace exposure. The null
association with household exposure stands in
contrast to the significantly positive associa-
tion reported for spouse exposure in the hos-
pital-based study by Lam et al. (33), also
conducted in Hong Kong.
Two ofthe larger hospital-based studies
include an early U.S. studyby Garfinkel et al.
(24) and a very recent study from Moscow
(31). The Garfinkel study retrospectively
identified lung cancer cases diagnosed in four
U.S. hospitals over the decade from 1971 to
1981. The investigators selected all female
lung cancer cases identified as nonsmokers in
the hospital records and conducted a careful
pathology review and follow-up interviews
(primarily with next ofkin) on smoking his-
tory. Forty percent ofwomen classified as
nonsmokers in the hospital records were
reported to have smoked at some time. Upon
review, it was determined that another 12%
were not lung cancer primaries. Patients with
colon cancer diagnoses were selected as con-
trols. Analysis of interview information on
passive smoking suggested a significantly ele-
vated risk with exposure to a heavily smoking
spouse but no association with workplace
exposure to ETS reported either within 5
years or 25 years of diagnosis. Workplace
exposure to ETS was reported for nearly all
controls (87%) for the prior 25 years butonly
for 20% of controls in the prior 5 years.
Zaridze and colleagues (31) conducted a
study oflung cancer cases diagnosed among
female Moscow residents from two cancer
treatment centers who had never smoked
cigarettes. Controls were drawn from other
oncology patients in the two facilities.
Although nearly halfof the controls (46%)
reported exposure to spouse's smoking, only
19% reported workplace exposure. Somewhat
elevated risks were noted for exposures to
smoking by a spouse, particularly from
spouses who smoked "papirosy," but not for
workplace exposures. Because the control
series included some cancers thought to be
smoking-related, analyses were conducted
both for the full control series and for a
restricted group including only breast and
endometrial cancer cases. Results were essen-
tiallythe same.
Null results for workplace ETS exposures
were also reported in a very small subset of
married respondents in a multioutcome study
in Great Britain (25), as well as among non-
smokers in larger lung cancer studies from
Greece (27), Japan (26), and Taiwan (29).
These studies all had low power to detect an
ORas lowas 1.4.
Two new European studies present
additional detail on workplace-associated
risks. The first is a study from Sweden (30) in
which male and female cases oflung cancer in
nonsmokers were drawn from the three major
hospitals treating lung cancer cases in
Stockholm County. Controls were drawn
from population registers for the catchment
areas ofthe three hospitals. Particular atten-
tion was directed to confirmation ofthe sub-
ject's smoking status via confirmatory
interviews with next-of-kin respondents. This
resulted in the identification and inclusion of
a small proportion ofoccasional smokers.
Although the overall point estimate for any
workplace exposure to ETS did not differ
from unity for either men or women, men
and women with exposure histories of 30
years or more duration had significantly ele-
vated odds ratios (OR = 2.2; 95% CI,
1.1-4.5). A second measure ofdose, years
weighted by amount, was also associated with
higher risks among those with 30 or more
hour-years ofexposure (OR = 2.4; 95% CI,
1.3-4.9). These riskassociations were adjusted
not only for the matching variables but also
for occasional smoking, occupational expo-
sure, residence in an urban area, and diet. An
interesting finding from the study was the
suggestion of a decrease in the OR for ETS
exposures (from any sources) with increasing
time since exposure. A similar suggestion was
made in an earlierstudy byAkiba et al. (34).
One ofthe most recentlypublished studies
is the European multicenter studycoordinated
by the International Agency for Research on
Cancer (IARC) (32), which is presented in
greater detail in an IARC monograph (35).
This study, which spanned seven countries
(12 data collection centers) and a 7-year ascer-
tainment period, offers the largest total num-
ber ofcases and controls (males and females
combined) to date in a single study with
workplace ETS estimates. The study protocol
is somewhat of an amalgam ofstudy types,
with center-specific variations in a number of
design features, including case and control
ascertainment criteria. The most important
difference cited by the authors was control
selection criteria, with five centers usinghospi-
tal controls, six using community controls,
and one using both. Although there were also
variations in the interview information col-
lected between centers, they all used a stan-
dard questionnaire for ETS exposures. The
pooled data analyses suggested only a modest
overall effect for any exposure to workplace
ETS for all subjects combined (Table 2) and
for women (Table 1). Point estimates for all
subjects were greater than 1.0 in 8 ofthe 12
study centers. Analyses using a measure of
duration ofexposure (level x hours/day x
years), however, suggested significant increas-
ing riskwith increased exposure (p for all sub-
jects = 0.01, p for women only = 0.03). As in
the Swedish study (30), which included some
subjects also included in the IARC study, a
suggestion ofdecreasing risk with increasing
time since last exposure was also noted.
Workplace point estimates did not differ
substantiallyfrom those for spouse exposures.
In general, the hospital-based studies
offer a balance ofstrengths and weaknesses to
this area of research. Most, because of their
case selection criteria, do not include proxy
interviews and hence include only informa-
tion directly from the respondent ofinterest.
Additionally, the use ofhospital controls is
likely to reduce the problem of differential
recall bias. Conversely, these studies have
greater propensity for selection bias and the
common use ofcancer controls (particularly
for other cancers that may be smoking
related) may tend to bias risk estimates
toward the null. This is ofspecial concern in
these studies because of the evidence that
ETS may be associated with a broader group
ofcancers than was previously believed based
only on risk relationships for active smoking
(36-38). Unfortunately, because oflimited
information reported in the publications, it is
not possible to systematically compare many
ofthe features ofprotocols employed. Most
studies do not specify the time period cov-
ered by ascertainment, the amount of retro-
spective ascertainment, or the temporal
concordance of case and control selection.
These timing issues may be ofconsequence,
as the prevalence of active smoking has
declined in many areas and workplace
restrictions on smoking have become more
common. Tremendous differences between
studies are evident in the assessment ofwork-
place ETS exposure, but less detail is given
for this than for household assessments.
Most studies report only crude OR estimates
or offer limited adjustment for other factors.
In addition small sample sizes make it
unlikely that such studies would be able to
reliably detect elevated risk relationships if
they exist.
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The large IARC study (32,35) builds on
both the general strengths and weaknesses of
hospital-based studies. This study, along with
the Swedish report (30), represents one ofthe
few studies that has had an opportunity to
comprehensively elicit information on a wide
spectrum ofparameters oflifetime exposures
to ETS. Observations from this effort suggest
modest risk associations that may vary with
time since exposure.
Population-Based Studies
inNonsmokingWomen
There are far fewer population-based studies
(17,18,39,40) of this extremely rare health
outcome (Table 3). This is not surprising,
given the labor-intensive efforts required to
fully ascertain all eligible cases quickly
enough to invite these individuals to partici-
pate in a personal interview. Lung cancer in
lifetime nonsmokers comprises an estimated
10% ofall lung cancers in U.S. women and
a much smaller proportion oflung cancers
in men (22,41). With the exception of one
study from northeastern China (40), all the
population-based studies with risk estimates
of ETS exposure in the workplace for non-
smoking women have been conducted in
the United States. The strength of the evi-
dence for risks of ETS exposure in the
workplace between these few studies,
however, is quite variable.
In a Los Angeles study designed to
evaluate lung cancer risk factors by cell type,
Wu and colleagues (39) separately evaluated
ETS risk relationships for the small subset of
women who had never smoked tobacco prod-
ucts. With regard to characterizing work-
place-associated risks, this studysuffered from
small sample size, low response rates, the lim-
itation ofexcluding proxy respondents, use of
telephone interviewing, and control selection
from neighborhood matching (which might
tend to overmatch by socioeconomic status,
and hence workplace exposure opportunity).
Table 2. Studies with estimates ofworkplace ETS exposure risks for lung cancer in nonsmoking men or men and women combined.
Study, location Cases/ Work OR Spouse OR Power1%)
(reference) controls Control selection Workplace measure (95% Cl)a (95% Cl)a OR =1.4
Kabat and Wynder, 25/25 Hospital Currentjob exposure 3.3 1.0 14
1984, U.S. (22) Men Match: age, race, hospital (60% othercancers)
lee etal, 1986, 10/98 Hospital Regular exposure(time 1.6 2.5 11
England (25) Men Match: age, region, ward notspecified)
Butler et al., 1988, 7 cases Cohort Workwith smoker
(48) 13, 575 P-Y Seventh DayAdventists (includes smokers) 1-10 yr 1.7 (0.2-6.7) 0.0 5
Men 11+yr 0.0 1.2(0.2-8.8)
Janerich etal., 1990, 191/191 Community 150 P-Y ofexposure 0.9(0.8-1.04) 0.9(0.6-1.6) 47b
NewYork(16) Men Match: age, sex, county(from DMV records)
Women
Kabat etal., 1995, 41/117 Hospital Forfourjobs lasting > 1 yr 1.02(0.5-2.1) 1.6(0.7-3.8) 22
U.S. (28) Men Match: age, hospital (61% other cancers)
Nyberg etal., 1998, 35/72 Community Detail from the IARC 1.9(0.5-6.7) 2.0(0.7-5.4) 14
Sweden (30) Men Match: age, hospital catchment area core questionnaire
Boffetta etal., 1998, 650/1540 Hospital (5 centers) Detail from a common 1.2 (0.9-1.5) 1.2(0.9-1.4) 97
[ARC (32) Men + Community (6 centers) questionnaire
Women Both (1 center)
Jockel, 1998, 17/236 Community Questionnaire "compatible" 2.7(0.7-9.7) 1.9(0.5-7.7) 24c
Germany(49) Men + "Individually matched" (criteria notspecified) with IARC instrument "High" exp "High" exp
Women
Abbreviations: DMV, Department of Motor Vehicles; exp, exposure; P-Y, person years. 'Crude or only age-adjusted odds ratios are available from most of the studies(16,22,25,32,48). Some of the more
recent studies (28,30,49) also adjust for other factors. bExposure prevalence in controls unknown-prevalence from Fontham et al. (18) used. cBased on exposure prevalence reported for workplace and
other sources of ETS.
Table 3. Population-based studies with estimates ofworkplace ETS exposure risks forlung cancer in nonsmoking women.
Figure Study, location Cases/ Percent Path. Response Work OR Spouse OR Power1%)
label (reference) controls Control selection Interview proxy conf. (%) rate (%) (95% CI)a (95% Cl)a Adjustments OR = 1.4
P1 Wu etal., 1985, 31/92 Neighborhood Phone 0 100 49 Adeno: 1.3 Adeno: 1.2 Age+ 18
LosAngeles Match: birth-year (0.5-3.3) (0.5-3.3) location
(39) Squam: 2.3 Squam: 1.0
(0.7-7.9) (1.0-7.6)
P2 Wu-Williams 415/602 Community In person 0 74 92 1.1a 0.7 Age + 84
etal.,1990, Match: age others
NE China(40)
P3 Brownson etal., 432/1166 Community Phone 65 76 70 1.2 1.3 Age + 89b
1992, Missouri DMV/HCFA (0.9-1.7) (1.0-1.7) previous
(17) Match: age Highest Highest lung disease
quartile quartile
P4 Fontham etal., 609/1247 Community In person 36 100 74 1.4 1.3 Age + 95
1994, U.S. multi- RDD/HCFA (1.1-1.7) (1.0-1.6) others +
center(18) Match: age, area 1.6c other ETS
(1.2-2.0)
Abbreviations: adeno, adenocarcinoma; path. conf., pathologic confirmations; DMV/HCFA, controls drawn from the files of the Department of Motor Vehicles and Health Care Financing Administration; RDD/HCFA, controls drawn from random digitdialing and files of the Health Care Financing Administration; squam, squamous cell carcinoma.'Corrected OR from Wells (10)is 1.2, with a calculated 95% Cl of 0.9-1.6. bExposure prevalence in controls unknown; prevalence from Fontham et al. (18) used. 0Data from reanalysis by Reynolds et al. (51)excluding nonworking women and adjusting for other
sources of ETS.
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A subsequent study by the same investigator
in China (40) was also unlikely to provide
strong evidence for ETS-associated risks
because of the very strong risk associations
that have been observed for home heating
and cooking practices (40,42-44). In a small
Denver study ofadenocarcinoma ofthe lung
(not tabled) that included 19 cases in non-
smoking women. Brownson et al. (45)
reported a suggestively elevated OR associ-
ated with 4 hr or more ofdaily passive smoke
exposure from household and workplace
sources combined (OR = 1.7; 95% CI,
0.4-3.0). This study reported no increased
risk for living with a spouse who smoked, but
information was not presented separately for
household or workplace exposures. The
Missouri study by Brownson and associates
(17) drew subjects from a study ofcurrent
nonsmokers (never smokers and former
smokers) that was designed primarily to eval-
uate radon-associated lung cancer risks
among women with a low prevalence ofwork
outside ofthe home in a residentially stable
community (46). Respondents in that study
were interviewed by telephone rather than in
person, and roughly two-thirds ofthe inter-
views were obtained from a proxy. A popula-
tion-based Florida study (not tabled)
providing one ofthe highest point estimates
for spouse effects reported that there was no
association between workplace ETS exposure
and lung cancer in nonsmoking women but
did not present any specific risk estimates
(47). The only study in this group, which
was designed explicitly to investigate the rela-
tionship between ETS exposure and lung
cancer, was the Fontham et al. study (18).
Conducted in five U.S. collaborating centers,
it is the only study ofthe population-based
group to report a statistically significant ele-
vated risk of lung cancer in nonsmoking
women exposed to ETS in the workplace.
Although modestly higher than the point esti-
mate for spouse exposures in this study, the
workplace OR is well within the CI for the
spouse estimate.
Studies IndudingNonsmokingMen
Only a few studies (16,22,25,28,30,32,
48,49) offer risk estimates for nonsmoking
men (Table 2). They include three older hos-
pital studies, the two studies by Kabat et al.
(22,28) and the study by Lee et al. (25) dis-
cussed above, which presented separate analy-
ses for men and women. The number ofmen
in these studies is even smaller than the num-
ber ofwomen, and the power to detect an
OR of 1.4 is less than 12% for each. A small
cohort study of California Seventh Day
Adventists, with only seven lung cancer cases
in men (and six in women), had insufficient
Seventh Day Adventists do not smoke, the
cohort study was not restricted to nonsmok-
ers and hence included a small proportion of
active smokers. A population-based study by
Janerich et al. (16) covering 23 counties in
the state ofNew York evaluated ETS-related
risks in a group ofcurrent nonsmokers. Of
these, 191 cases and individually matched
controls (drawn from New York Department
ofMotor Vehicle records) were identified as
lifetime nonsmokers. This study found no
evidence ofworkplace-associated ETS risks
but also reported little or no association with
adult household exposures. Unfortunately,
risk estimates were not presented separately
for men and women. In a recent report from
the American Cancer Society's large prospec-
tive Cancer Prevention Study 11(50), ETS
exposure in the workplace was not associated
with lung cancer mortality, but no specific
risk estimates were given.
Also included are three recent European
studies, those from Sweden (30) and
Germany (49), and the IARC multicenter
study (32). The Swedish and IARC studies,
which provide separate workplace point esti-
mates for women (who constitute the
majority ofcases among never smokers), are
discussed in some detail above. The German
study, also included in the IARC multicenter
study, presents separate point estimates for
lifetime nonsmokers and occasional smokers.
Among men and women combined classified
Study(reference)
as never smokers, point estimates for high
exposures to ETS from a spouse (OR = 1.87;
95% CI, 0.45-7.74) or from the workplace
(OR = 2.67; 95% CI, 0.74-9.67) were both
elevated, although with wide CI values in this
small sample. Further adjustment for dietary
factors had little effect on the risk estimates
from this study. Point estimates for men only,
or for men and women combined in these
studies, were similar to those for women only
when reported separately.
The generally null results and low power
from this group ofstudies provide little addi-
tional information on workplace risks from
ETS exposure. To remove anysex-related
bias, the remainder of this article will focus
on studies ofwomen only.
StudieswithExposure-Response
Estimates
Only five studies present estimates for
exposure-response effects from ETS (Table
4). Two ofthese, the small British study by
Lee et al. (25) and the more recent study
of Kabat et al. (28), provide risk estimates
for qualitative measures of exposure.
Neither ofthese studies observed an overall
effect for workplace ETS exposure, and nei-
ther provides strong evidence for an expo-
sure-response effect. Exposure-response
estimates for a quantified exposure measure
are available from the U.S. (18) and IARC
(32) multicenter studies, as well as from the
Table 4. Studies with workplace ETS dose-response estimates for nonsmoking women.
Qualitative assessments
Lee etal., 1986(25)
Kabat et al., 1995(28)
Quantitative estimates
Fontham etal., 1994(18)
Reynolds et al., 1996(51)
Boffetta etal., 1998 (32)
power to detect stable workplace risk esti-
mates (48). In addition, although most
Exposure level Odds ratio (95% Cl)
Not atall
Little
Average/a lot
Low
Intermediate
High
Years of exposure
0
1-15
16-30
>30
0
1-15
16-30
>30
Years of exposure
0
1-29
30-38
>39
Level x hr/day x yr
0
0.1-46.1
46.2-88.9
>89.0
1.0
1.2
0.0
1.0
0.9(0.4-2.1)
1.4(0.6-2.8)
1.0
1.3 (1.01-1.7)
1.4(1.04-1.9)
1.9(1.2-2.8)
p fortrend= 0.001
1.0
1.5(1.1-1.9)
1.6 (1.1-2.2)
2.1 (1.4-3.2)
p fortrend< 0.001
1.0
1.1 (0.9-1.5)
1.5(0.9-2.4)
1.2 (0.7-2.3)
p fortrend= 0.10
1.0
1.0 (0.8-1.4)
1.1 (0.7-1.8)
1.9(1.1-3.2)
p fortrend= 0.03
Adjustment
Age, spouse smoking,
marital status
Age, education, hospital
type
Age, race, study area,
dietaryfactors, family
history of lung cancer,
high-risk occupations
All of the above plus
other sources of ETS
exposure. Referent
excludes nonworking
women.
Age
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new Swedish study (30). Data from the U.S.
study in Table 4 are drawn from the original
publication of the full multicenter study
results (18) and from a follow-up analysis
that included only working women and fur-
ther adjustment for other sources of adult
ETS exposure (51). The latter analysis,
although presenting slightly higher point esti-
mates ofrisk, provided results that are statisti-
cally indistinguishable from those of the
original paper. Data from this study suggest a
doubling of risk for women reporting 30 or
more years ofworkplace ETS exposure. The
IARC study (35) provides risk estimates for
years ofworkplace exposure as well as for a
duration measure incorporating years and
amount (level and hours per day). Only the
latter measure suggests a dose-response trend,
largely because ofthe nearly 2-fold risk at the
highest category ofexposure. Results in Table
4 are those reported for women only, but the
relationship is similar to that for all subjects
combined. The Swedish study (30) (not
tabled) does not present data separately for
women but suggests about a doubling ofrisk
for subjects with more than 30 years of
reported workplace exposure.
Additional Observations
A number of studies that did not directly
examine risk estimates for workplace ETS
exposure nonetheless offer relevant observa-
tions on risk estimates from spouse exposure,
stratified by occupational or residential char-
acteristics. The study by Akiba et al. (34) of
lung cancer in nonsmoking women in the
cohort ofatomic bomb survivors followed by
the Radiation Effects Research Foundation
noted substantially higher risk estimates for
heavy ETS exposure from spouses among
women who were employed as blue-collar
workers (OR = 10.4; 95% CI, 1.6-66.7)
than among women employed in white-col-
lar occupations (OR = 1.6; 95% CI,
0.6-4.1) or among women who were house-
wives (OR = 1.5; 95% CI, 0.7-3.3). This
association suggested broader exposure to
ETS from other sources in addition to
spouses in these lower socioeconomic groups
where smoking is more prevalent.
Studies based on self-report and biomarkers
have shown that a nonsmoker married to a
smoking spouse is more likely to be exposed
to tobacco smoke in other settings as well
(52,53). Similar findings from an earlier
study from Stockholm County, Sweden (54)
indicated that risk estimates were higher for
women exposed both at home and at work
than for women exposed in only one setting.
A somewhat contrary observation in a small
mortality study from Pennsylvania (55)
found that women who did not work outside
the home had higher risks for lung cancer
mortality with exposure to a smoking spouse
(OR = 1.9) than women who worked outside
the home (OR = 0.8).
In his landmark cohort study of over
91,000 women, Hirayama (56) observed that
risk estimates for spouse exposure tended to
be higher among women living in more rural
areas. He attributed that association to the
fact that rural couples experienced longer
periods of mutual contact than couples in
urban environments. Likewise, an occupa-
tional mortality study from China reported
higher lung cancer standard mortality ratios
for women who did not work outside the
home than among working women (44).
These mortality studies may be subject to a
healthy worker bias, since the lung cancer
decedents may have been less likely to be
employed at the time of their death. As a
group these studies provide indirect and ill-
defined evidence at best for the effects of
workplace ETS exposures.
Issues Addressed bythe
U.S. Multicenter Study
Because the U.S. multicenter study reported
by Fontham and associates (18) was specifi-
cally designed to address some of the
methodologic limitations ofearlier studies of
passive smoking and lung cancer, design fea-
tures ofthe study are considered in detail. It
was designed as a single study, with a single
protocol, conducted in a small number of
closely collaborating centers. Although some
of the features of this study were incorpo-
rated into earlier efforts, the combination
was unique to the multicenter study. Issues
ofimportance include:
* Misclassification of smoking status.
Because of the powerful effect ofactive
smoking on lung cancer risk, inclusion of
former smokers in studies ofthis type poses
a potentially serious source ofbias in assess-
ing the effects ofETS exposure. The U.S.
multicenter study employed a number of
strategies to minimize this problem. First, a
three-tiered approach was used in assessing
the smoking status ofthe cases: medical
records review, physician query, and
respondent report. Respondent informa-
tion for both cases and controls was
obtained first in a screening interview and
again in a more in-depth interview. In
addition, for both cases and controls, urine
cotinine analyses were employed to elimi-
nate misreported current smoking. This
latterprocedure resulted in the exclusion of
two cases and 25 controls with urinary
cotinine measures of 100 ng/mg or higher
who reported themselves to be lifetime
nonsmokers. Finally, the study employed a
rapid case ascertainment procedure to limit
the number ofproxyinterviews required.
* Histopathologic specificity. Because ofthe
interest in whether certain cell types of
lung cancer, particularly Kreyberg II
tumors (squamous cell, large cell, and
small cell carcinomas), may be morelikely
to be linked with tobacco exposure, the
Fontham et al. study (18) was designed to
have a sufficiently large sample size to
separately estimate ETS risks for the ade-
nocarcinomas and other cell types com-
bined. Pathology slides for the study cases
were submitted for independent reviewby
the studypathologist. This review resulted
in the further elimination often cases oth-
erwise eligible (two benign lesions, three
metastatic carcinomas, and five other
types ofcancer) for the study, and a more
detailed classification oflung cancer cell
types for thestudy cases.
* Recall bias. Because of the potential for
recall bias in studies of a serious and fatal
disease using healthy controls, the study
by Fontham et al. (41) incorporated two
control groups during the initial years:
colon cancer controls and population
controls. In an initial evaluation ofstudy
results, risk estimates were comparable for
the two control groups, so the colon
cancer control series was discontinued for
the remainingyears ofthestudy.
* Source ofETS exposure. Because the pri-
mary hypothesis of interest for this study
related to passive smoking, the major
thrust ofthe questionnaire was a detailed
assessment of exposure to ETS. This
included an extensive series ofquestions
to assess timing ofexposure, quantity of
exposure, and sources ofexposure for the
lifetime ofthe respondent.
* Confounders and other risk factors. To
estimate ETS-associated risks for lung
cancer without potential for confounding,
the Fontham study was designed to collect
a broad spectrum ofpotentially important
covariables and a sufficiently large sample
size to conduct multivariate analyses.
Point estimates for ETS exposure risks
were presented with adjustments not only
for age, race/ethnicity, educational status
and study area, but also for dietary fac-
tors, family history, and employment in
putativelyhigh-riskoccupations.
Many of these same issues also were
addressed in the IARC European multicenter
study (32), although with less consistency
between study centers. There was a fair
amount ofvariability in the study protocol
from center to center, which also yielded
some heterogeneity in point estimates
between centers. Nonetheless, this very large
study provides the first stable point estimates
for Western European populations and pro-
vides some valuable additional methodologic
information. Although active smokers were
also recruited in many ofthe study centers,
the analysis presented by Boffetta and
Environmental Health Perspectives * Vol 107, Supplement 6 * December 1999 870WORKPLACE ETS AND LUNG CANCER
colleagues was restricted to individuals who
reported not smoking more than 400 ciga-
rettes in their lifetime. Validation studies on
active smoking status were carried out in
three of the centers via confirmatory inter-
views with next ofkin. Data from this effort
suggested a misclassification rate of only
1.2%. Histologic confirmation was obtained
for 76% ofthe cases. Roughly half the study
centers used hospital controls and half used
community controls. Separate analyses with
each type ofcenter suggested no difference in
ETS effects. Similar to the Fontham study,
the IARC study paid special attention to
detailed ETS exposure histories including
information on timing, dose and sources, and
included (in some study centers) a wide
spectrum ofcovariables.
Summary
Of the many studies published to date that
provide some evidence for ETS-associated
risks for lung cancer in nonsmokers, few have
explicitly addressed workplace sources ofETS
exposure. The hospital-based and population-
based studies that provide specific workplace
ETS point estimates for nonsmoking women
are summarized in Figure 1. Estimates ofthe
ORs, with their respective 95% CI values (if
provided by the authors), are plotted against
the power to detect a minimal OR of 1.4.
Only three studies have greater than 85%
1.0-
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Figure 1. Workplace ETS exposure risk estimates from
studies of nonsmoking women. Point estimates are pre-
sented for the odds ratio and where available by the
authors, 95% confidence interval. Squares represent
hospital-based studies and are referenced to studies Hi
through H12 from Table 1. Diamonds represent popula-
tion-based studies and are referenced to studies P1
through P4 from Table 3. These values are from the orig-
inal publications and do not incorporate the recent cor-
rections fron Wells (10) that are noted on the tables.
power to detect an odds ratio ofthat magni-
tude: the Missouri study by Brownson and
colleagues (17) and the large U.S. and
European multicenter studies (18,32). Each
ofthese suggests an elevation ofrisk, although
only the point estimate from Fontham et al.
(18) has a 95% CI that excludes 1.0.
It is noteworthy that the workplace risk
estimates across studies tend to be consistent
with those from exposure to a smoking
spouse. This consistency raises the important
issue ofexposure opportunities by source and
setting. National survey data for 1995 sug-
gested that roughly a quarter ofnonsmoking
work force members are exposed to ETS by
their co-workers (57). This estimate is simi-
lar to that from California's baseline tobacco
survey at the beginning of the decade (58),
before statewide smoking bans were legisla-
tively mandated. Notably, however, the
prevalence of reported workplace exposure
has been very much a function ofworkplace
smoking policy. Among nonsmoking
Californians who worked indoors between
July 1990 and June 1991, 31% reported
ETS exposure at work. This ranged from
52% exposed in workplaces with no smoking
restrictions, to 50% in workplaces with
minor restrictions, to 24% in workplaces
prohibiting smoking in the work area, to
10% in workplaces where there was a total
ban on smoking. Additionally, since a num-
ber of studies suggest that certain occupa-
tional groups may have unusually high
workplace ETS exposure (6-9,59), questions
ofworkplace-associated risks need to incor-
porate better exposure information than is
traditionally available from epidemiologic
studies on this topic.
The limits of human health studies to
detect small and difficult-to-measure risks, as
is the case for ETS, was eloquently discussed
in the editorial accompanying the recently
published IARC study of ETS and lung
cancer (60). The human health evidence
from epidemiologic studies provides only one
piece of the puzzle in this regard. Together
with exposure and biomarker information,
the evidence suggests that exposure to ETS,
whether at home or at work, is a risk factor
for lung cancer among nonsmokers.
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